Literature DB >> 15979846

Prostacyclin receptor induces STAT1 and STAT3 phosphorylations in human erythroleukemia cells: a mechanism requiring PTX-insensitive G proteins, ERK and JNK.

Rico K H Lo1, Helen Wise, Yung H Wong.   

Abstract

The ability of the human prostacyclin receptor (hIP) to regulate the activities of signal transducers and activators of transcription (STATs) has not yet been documented. In the present study, we have delineated the mechanism by which hIP induces STAT3 phosphorylations in human erythroleukemia (HEL) cells. Stimulation of endogenous hIP by its specific agonist, cicaprost, resulted in STAT3 Tyr705 and Ser727 phosphorylations in a time- and concentration-dependent manner. Cicaprost-induced STAT3 Tyr705 and Ser727 phosphorylations were resistant to pertussis toxin (PTX) treatment, suggesting that these responses were mediated through PTX-insensitive G proteins. In addition, extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK), but not p38 MAPK, were shown to be phosphorylated by cicaprost in a time- and concentration-dependent manner via PTX-insensitive G proteins. The levels of the interaction between STAT3, ERK and JNK were enhanced by cicaprost treatment. The involvement of Raf-1, MEK1/2 and JNK in cicaprost-induced phosphorylations of STAT3 was illustrated by the use of their selective inhibitors. In contrast, p38 MAPK did not appear to be required. Similar observations were obtained with STAT1 upon stimulation by cicaprost. Taken together, these results demonstrate for the first time that hIP activation by cicaprost can lead to STAT1 and STAT3 phosphorylations via signaling pathways involving PTX-insensitive G proteins, ERK and JNK.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15979846     DOI: 10.1016/j.cellsig.2005.05.001

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  5 in total

1.  The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.

Authors:  Lauren L C Marotta; Vanessa Almendro; Andriy Marusyk; Michail Shipitsin; Janina Schemme; Sarah R Walker; Noga Bloushtain-Qimron; Jessica J Kim; Sibgat A Choudhury; Reo Maruyama; Zhenhua Wu; Mithat Gönen; Laura A Mulvey; Marina O Bessarabova; Sung Jin Huh; Serena J Silver; So Young Kim; So Yeon Park; Hee Eun Lee; Karen S Anderson; Andrea L Richardson; Tatiana Nikolskaya; Yuri Nikolsky; X Shirley Liu; David E Root; William C Hahn; David A Frank; Kornelia Polyak
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  Inhibition of Notch1 signaling overcomes resistance to the death ligand Trail by specificity protein 1-dependent upregulation of death receptor 5.

Authors:  A Fassl; K E Tagscherer; J Richter; J De-Castro Arce; C Savini; F Rösl; W Roth
Journal:  Cell Death Dis       Date:  2015-10-15       Impact factor: 8.469

3.  Effect of QSKL on MAPK and RhoA Pathways in a Rat Model of Heart Failure.

Authors:  Kai Xia; Qiyan Wang; Chun Li; Zifan Zeng; Yong Wang; Wei Wang
Journal:  Evid Based Complement Alternat Med       Date:  2017-04-18       Impact factor: 2.629

4.  Dual blockage of STAT3 and ERK1/2 eliminates radioresistant GBM cells.

Authors:  Bowen Xie; Lu Zhang; Wenfeng Hu; Ming Fan; Nian Jiang; Yumei Duan; Di Jing; Wenwu Xiao; Ruben C Fragoso; Kit S Lam; Lun-Quan Sun; Jian Jian Li
Journal:  Redox Biol       Date:  2019-04-09       Impact factor: 11.799

5.  Gene expression and biological processes influenced by deletion of Stat3 in pulmonary type II epithelial cells.

Authors:  Yan Xu; Machiko Ikegami; Yanhua Wang; Yohei Matsuzaki; Jeffrey A Whitsett
Journal:  BMC Genomics       Date:  2007-12-10       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.